Ricerca

Pubblicazioni IRIS

• The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
  Anno: 2019
• Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
  Anno: 2017
• Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
  Anno: 2017
• Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma
  Anno: 2016
• Afatinib for the treatment of non-small cell lung cancer
  Anno: 2015